cephalosporin c has been researched along with Febrile Neutropenia in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 22 (81.48) | 24.3611 |
| 2020's | 5 (18.52) | 2.80 |
| Authors | Studies |
|---|---|
| Andrick, B; Leri, F; Okubo, L; Rampulla, R | 1 |
| Esumi, S; Higashionna, T; Kitamura, Y; Murakawa, K; Sendo, T; Ushio, S | 1 |
| Crawford, R; Hobbs, ALV; Hobbs, DA; Perkins, NB | 1 |
| Bernardi, M; Castagna, A; Castiglion, B; Ciceri, F; Clerici, D; Corti, C; Farina, F; Giglio, F; Greco, R; Liberatore, C; Lorentino, F; Mastaglio, S; Oltolini, C; Pavesi, F; Peccatori, J; Ripa, M; Scarpellini, P; Tassan Din, C | 1 |
| Blumenthal, KG; Fu, X; Mancini, CM; Naureckas Li, C; Zhang, Y | 1 |
| Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
| Barreto, JN; Dierkhising, RA; Gangat, N; Mara, KC; Tosh, PK; Yemm, KE | 1 |
| Click, Z; Geswein, L; Varughese, C | 1 |
| Horita, N; Kaneko, T; Namkoong, H; Shibata, Y; Watanabe, H | 2 |
| Akova, M; Averbuch, D; Calandra, T; Cordonnier, C; Engelhard, D; Gyssens, IC; Kern, WV; Klyasova, G; Livermore, DM; Marchetti, O; Mikulska, M; Orasch, C; Viscoli, C | 1 |
| Amit, O; Avivi, I; Ben-Ami, R; Halavy, Y; Katchman, E; Kor, S; Paran, Y; Ram, R; Yachini, B | 1 |
| Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Kang, JH; Kim, HK; Lee, DG; Lee, JW | 1 |
| Ashley, DM; Babl, FE; Barnes, C; Barnett, P; Donath, S; Orme, LM | 1 |
| Azuma, H; Kobayashi, R; Sano, H; Sarashina, T; Suzuki, D; Toriumi, N; Yoshida, M | 1 |
| Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K | 1 |
| Bae, EY; Cho, B; Chung, NG; Han, SB; Jeong, DC; Jung, SW; Kang, JH; Kim, HK; Lee, DG; Lee, JW; Park, YJ | 1 |
| Abdallah, DI; Estaitieh, N; Ibrahim, A; Jisr, T; Moghnieh, R; Mugharbil, A; Sinno, L; Ziade, F | 1 |
| Gardner, JH; Hahn, U; Lehman, S; Peake, SL; Roberts, JA; Roberts, MS; Sime, FB; Tiong, IS; Warner, MS | 1 |
| Aamir, M; Abrol, P; Punia, H; Sharma, D | 1 |
| Afifi, IK; Elgamasy, MA; Hagag, AA; Hassan, SM | 1 |
| Ebi, N; Fujita, M; Ichinose, Y; Inoue, Y; Ishida, M; Kishimoto, J; Matsumoto, T; Takayama, K; Wataya, H | 1 |
| Gustinetti, G; Mikulska, M | 1 |
| Grove, M; Jones, DR; Kiel, PJ; Lowe, C; Moore, D; Neeb, J; O'Donnell, JN; Rhodes, NJ; Rose, D; Scheetz, MH; Thoele, K; Whited, L | 1 |
| Gotoh, Y; Kamiyama, H; Kanoh, H; Kawamoto, Y; Ueda, A; Yamamoto, A; Yamamoto, S; Yamashita, Y; Yuhki, Y | 1 |
| Cluck, D; Kennedy, L; Ohl, C; Williamson, JC; Wrenn, RH | 1 |
| Alvarez, CA; Puentes, GA; Quiroga, C; Ruiz, A; Támara, JR | 1 |
1 review(s) available for cephalosporin c and Febrile Neutropenia
| Article | Year |
|---|---|
Bloodstream infections in neutropenic cancer patients: A practical update.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Disease Management; Drug Resistance, Bacterial; Febrile Neutropenia; Fluoroquinolones; Gram-Negative Bacteria; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pre-Exposure Prophylaxis; Risk Factors | 2016 |
8 trial(s) available for cephalosporin c and Febrile Neutropenia
| Article | Year |
|---|---|
Extended vs Bolus Infusion of Broad-Spectrum β-Lactams for Febrile Neutropenia: An Unblinded, Randomized Trial.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Ceftazidime; Cephalosporins; Febrile Neutropenia; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2018 |
Outpatient versus inpatient IV antibiotic management for pediatric oncology patients with low risk febrile neutropenia: a randomised trial.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Inpatients; Male; Neoplasms; Outpatients; Quality of Life; Risk Factors | 2014 |
A randomized trial of cefozopran versus cefepime as empirical antibiotic treatment of febrile neutropenia in pediatric cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Infant; Infant, Newborn; Male; Neoplasms | 2014 |
Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: A prospective, randomized study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Young Adult | 2015 |
Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2015 |
A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Fever; Humans; India; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tertiary Care Centers; Treatment Outcome | 2016 |
The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents; Cefepime; Cephalosporins; Febrile Neutropenia; Female; Humans; Lung Neoplasms; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins | 2016 |
Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Empirical Research; Febrile Neutropenia; Female; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
18 other study(ies) available for cephalosporin c and Febrile Neutropenia
| Article | Year |
|---|---|
Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Cohort Studies; Febrile Neutropenia; Fever; Humans; Retrospective Studies; Vancomycin | 2022 |
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Topics: Anti-Bacterial Agents; Cefepime; Cefozopran; Cephalosporins; Febrile Neutropenia; Humans; Lung Neoplasms; Retrospective Studies; Treatment Outcome | 2022 |
Time to defervescence evaluation for extended- vs. standard-infusion cefepime in patients with acute leukemia and febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Febrile Neutropenia; Humans; Leukemia, Myeloid, Acute; Retrospective Studies | 2022 |
The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Autografts; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Retrospective Studies; Tazobactam; Treatment Outcome; Young Adult | 2021 |
Association of beta-lactam allergy documentation and antibiotic use in patients with febrile neutropenia.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Hypersensitivity; Febrile Neutropenia; Humans; Meropenem; Penicillins | 2021 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult | 2018 |
Comparison of antipseudomonal beta-lactams for febrile neutropenia empiric therapy.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: authors' response.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans | 2018 |
Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.
Topics: Anti-Bacterial Agents; Cephalosporins; Febrile Neutropenia; Fever; Humans | 2018 |
Comparison of antipseudomonal β-lactams for febrile neutropenia empiric therapy: systematic review and network meta-analysis: authors' reply.
Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Febrile Neutropenia; Fever; Humans; Neoplasms; Network Meta-Analysis | 2018 |
Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children.
Topics: Adult; Age Factors; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Streptococcal Infections; Viridans Streptococci | 2013 |
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cefepime; Cephalosporins; Child; Escherichia coli; Escherichia coli Infections; Febrile Neutropenia; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies | 2015 |
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation w
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Cephalosporins; Child; Child, Preschool; Drug Resistance, Bacterial; Enterobacteriaceae; Febrile Neutropenia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Lebanon; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Young Adult | 2015 |
Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Blood Cell Count; Candida; Cefepime; Cephalosporins; Child; Child, Preschool; Egypt; Febrile Neutropenia; Female; Fungi; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Male; Pharynx; Pseudomonas aeruginosa; Staphylococcus aureus | 2016 |
Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Prospective Studies | 2016 |
Relationship between PK/PD of Cefepime and Clinical Outcome in Febrile Neutropenic Patients with Normal Renal Function.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Creatinine; Dose-Response Relationship, Drug; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Treatment Outcome | 2016 |
[Demographics, morbidity, and mortality febrile neutropenic adult patients treated with cefepime].
Topics: Adult; Anti-Bacterial Agents; Cefepime; Cephalosporins; Colombia; Comorbidity; Cross-Sectional Studies; Demography; Febrile Neutropenia; Female; Humans; Male; Middle Aged | 2012 |